#AACR25: Scientists alarmed about future of cancer researchnews2025-04-30T15:28:33+00:00April 30th, 2025|Endpoints News|
Artios cancer drug shrinks subset of tumors in early studynews2025-04-29T19:46:12+00:00April 29th, 2025|Endpoints News|
Novartis Q1 earnings: Company raises 2025 bar after beating sales expectationsnews2025-04-29T10:28:55+00:00April 29th, 2025|Endpoints News|
#AACR25: Boehringer’s updated results in HER2-mutated lung cancer impressnews2025-04-28T13:59:26+00:00April 28th, 2025|Endpoints News|
#AACR25: GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancernews2025-04-28T10:36:06+00:00April 28th, 2025|Endpoints News|
#AACR25: Keytruda around head and neck cancer surgery cuts chance of disease coming backnews2025-04-28T07:05:13+00:00April 28th, 2025|Endpoints News|
#AACR25: Revolution’s KRAS drug shows potential in early cut of lung cancer datanews2025-04-28T07:05:05+00:00April 28th, 2025|Endpoints News|
J&J reports durability data for bladder cancer ‘pretzel’ drugnews2025-04-26T18:00:42+00:00April 26th, 2025|Endpoints News|
FDA chief Makary talks expediting drug approvals, RIFs and the abortion pillnews2025-04-25T19:27:20+00:00April 25th, 2025|Endpoints News|
Akeso reveals survival data for Keytruda-beating cancer drugnews2025-04-25T17:03:58+00:00April 25th, 2025|Endpoints News|
